DW Healthcare Partners
VC Fund
Toronto, Canada
DW Healthcare Partners is a Toronto-based private equity firm that invests in the healthcare sector.
- Total investments:
- 24
- Last investment:
- Lead investor:
- 79%
- Fund size:
- $610M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries DW Healthcare Partners invests in
Stages DW Healthcare Partners invests in
Countries DW Healthcare Partners invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Aaron Kennedy
|
|||
Aly Champsi
|
|||
Andrew Carragher
|
|||
Eric Moore
|
|||
Investment Focus
Industry
- Health Care 12 (50%)
- Education 4 (17%)
- Health Diagnostics 4 (17%)
- Medical 3 (13%)
- Hospital 3 (13%)
Stage
- Private Equity 18 (75%)
- Funding Round 2 (8%)
- Series A 1 (4%)
- Series B 1 (4%)
Country
- United States 19 (79%)
- Canada 1 (4%)
- Belgium 1 (4%)
- Ireland 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Aaron Kennedy
Vice President
|
Vice President | Total investments: 0 | Find email | |
|
Aly Champsi
Managing Director and Partner
|
Managing Director and Partner | Total investments: 1 | Find email | |
|
Andrew Carragher
Founder, Managing Director
|
Founder, Managing Director | Total investments: 1 | Find email | |
|
Eric Moore
Principal
|
Principal | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
LKC Technologies, Inc. (LKC)
|
When vision issues impact your everyday life, LKC Technologies is here to help. Building on over 40 years of experience in the visual electrophysiology field, the RETeval® device is transforming the industry for adults and children alike. Eye care professionals and researchers around the world are talking about this revolutionary handheld ERGdevice from LKC Technologies. Offering full flash and flicker ERG and VEP testing to gather objective, functional data within minutes, the RETeval device brings comprehensive electrophysiology technology to any office or clinical setting. LKC Technologies is committed to developing innovative products that lead to the preservation and treatment of sight. LKC Technologies: Vision Defined™. Visit www.LKC.com for more. | Private Equity / Jun 12, 2023 | |
MedLearning
|
MedLearning is a division of Ultimate Medical Academy, is a full-service accredited medical education company. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed todeliver the highest level of outcomes for not only the practitioner but also the patient. | Private Equity / Jan 03, 2023 | |
PCG Public Partnerships
|
We make it easier for participants to create their own opportunities. | Private Equity / Aug 08, 2022 | |
Vets Plus
|
Vets Plus, Inc. is a full-service manufacturer of animal nutritional supplements and treats for livestock and companion animals. Since 1990, customers have sought out Vets Plus for their strength in developing innovative formulations in a variety of dosage forms. With a focus on quality, Vets Plus has provided customers with high-quality productstested for efficacy, stability, and safety. All products are manufactured in the United States, distributed nationally, and exported to more than 20 countries. | Private Equity / Jan 10, 2022 | |
|
Vets Plus
|
Vets Plus, Inc. is a full-service manufacturer of animal nutritional supplements and treats for livestock and companion animals. Since 1990, customers have sought out Vets Plus for their strength in developing innovative formulations in a variety of dosage forms. With a focus on quality, Vets Plus has provided customers with high-quality productstested for efficacy, stability, and safety. All products are manufactured in the United States, distributed nationally, and exported to more than 20 countries. | Private Equity / Jan 10, 2022 | |
Noble Pharma
|
Noble Pharma, LLC is an FDA-approved manufacturing facility focused on developing and manufacturing extremely palatable products for the animal health market. With more than 50,000 square feet, Noble has the ability to manufacture soft chews, creams, ointments, suspensions, tablets, powders, and pastes. | Private Equity / Jan 10, 2022 | |
|
Noble Pharma
|
Noble Pharma, LLC is an FDA-approved manufacturing facility focused on developing and manufacturing extremely palatable products for the animal health market. With more than 50,000 square feet, Noble has the ability to manufacture soft chews, creams, ointments, suspensions, tablets, powders, and pastes. | Private Equity / Jan 10, 2022 | |
Bio Agri Mix
|
Canada’s largest feed medicant supplier, develop, distribute and market a wide range of antimicrobials and other feed additives to enhance animal health. their unique granulated feed additives contribute to. | Private Equity / Jul 27, 2021 | |
CareXM
|
CareXM is a provider of virtual care and patient engagement solutions for post-acute and nonacute healthcare providers. | Private Equity / Nov 16, 2020 | |
Cefaly Technology
|
CEFALY Technology is a medical company with a field of activities that covers various therapeutic means: biotechnology, pharmaceutical and medical devices. A highly skilled team of engineers and medical doctors collaborates with several universities on international research projects. For instance | Private Equity / Aug 08, 2019 | |
| See all 24 investments → | |||
Co-Investors
1/0 Capital
1 deal together
Five Points Capital
1 deal together
Blackstone
1 deal together
Colchis Capital Management
1 deal together
Fenway Summer Ventures
1 deal together
Invus
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does DW Healthcare Partners invest in?
DW Healthcare Partners invests primarily in Health Care, Education and Health Diagnostics startups, most often at Private Equity and Funding Round stage. Most of the 24 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact DW Healthcare Partners?
Public channels for DW Healthcare Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at DW Healthcare Partners?
The team at DW Healthcare Partners includes Aaron Kennedy (Vice President), Aly Champsi (Managing Director and Partner) and Andrew Carragher (Founder, Managing Director). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
